Today, DailyBurn™, a leading health and fitness program, unveiled a revolutionary, personalized fitness platform that delivers daily custom-designed video workouts using DailyBurn’s IntelliBurn™ technology. The new DailyBurn brings fitness to members’ fingertips, anytime, anywhere by streaming HD-quality custom workouts, personal result metrics, and nutrition and healthy living tools to users’ smartphone, computer, tablet or television every day.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53507-dailyburn-intelliburn-technology-daily-custom-designed-video-workouts
For 25 years now the DAA has worked to support people living with HIV, while actively promoting HIV prevention and sexual health awareness in the general population.
Danica Patrick will take to the track with a new primary sponsor as the blue-and-white No. 10 Aspen Dental Chevrolet SS makes its debut at the Kobalt 400 NASCAR Sprint Cup Series race at Las Vegas Motor Speedway this weekend. And she’ll do it sporting a blue firesuit selected by fans who voted in the Danica's New Suit Sweepstakes.
Patrick first teamed up with Aspen Dental, one of the largest and fastest-growing networks of dental care providers in the U.S. with more than 430 locations in communities across 27 states, last fall. Since that time, she has helped to shine a spotlight on an often overlooked healthcare issue – oral health – by championing the launch of Aspen Dental's Healthy Mouth Movement, a community-giving initiative designed to deliver free dental care to thousands of people in need in communities across the U.S., and oral health education to millions more.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/66081-aspen-dental-danica-patrick-new-primary-sponsor-las-vegas-motor-speedway
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
CVS/pharmacy, the nation’s leading retail pharmacy, and MinuteClinic, the largest retail health care clinic provider in the U.S., today announced that flu vaccinations are now available at all of its locations nationwide. CVS/pharmacy has more than 7,000 locations and MinuteClinic has more than 500 locations inside select CVS/pharmacy stores.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvspharmacy/45561/
CVS/pharmacy and MinuteClinic announced their “You vs. Flu” campaign today. Flu vaccinations are now available at all CVS/pharmacy and MinuteClinic locations nationwide to help consumers win against the flu. CVS/pharmacy has more than 7,200 locations and MinuteClinic has nearly 600 locations inside select CVS/pharmacy stores.
Flu shots are being provided by CVS pharmacists and MinuteClinic nurse practitioners and physician assistants every day, including evenings and weekends, with no appointment necessary. The Centers for Disease Control and Prevention (CDC) recommends that everyone ages six months and older get a flu shot as soon as vaccine is available, including those who were vaccinated last flu season.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51328-cvs-minuteclinic-flu-shot
CVS Health (NYSE:CVS), the nation’s largest pharmacy innovation company, today announced Be The First, a five-year $50 million initiative to help deliver the nation’s first tobacco-free generation. Through this initiative, which is funded through CVS Health and the CVS Health Foundation, the company is extending its commitment to help people lead tobacco-free lives. Recognizing that tobacco use is the leading preventable cause of disease and death in the United States and that youth use of some tobacco products is on the rise, Be The First comprises comprehensive education, advocacy, tobacco control and healthy behavior programming in partnership with organizations uniquely positioned to tackle this public health challenge.
“We are at a critical moment in our nation’s efforts to end the epidemic of tobacco use that continues to kill more people than any other preventable cause of death, and threatens the health and well-being of our next generation,” said Troyen A. Brennan, M.D., M.P.H., and Chief Medical Officer for CVS Health. “Ensuring our youth stay tobacco-free requires increased education and awareness of healthy behaviors. We’re partnering with experts across the public health community who have established best practices to help prevent tobacco use. And, by establishing more public-private partnerships to implement these strategies more aggressively, we can help increase the number of people leading tobacco-free lives and move us one step closer to delivering the first tobacco-free generation.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7775151-cvs-health-be-the-first/
CVS Caremark (NYSE: CVS) announced today that it will stop selling cigarettes and other tobacco products at its more than 7,600 CVS/pharmacy stores across the U.S. by October 1, 2014, making CVS/pharmacy the first national pharmacy chain to take this step in support of the health and well-being of its patients and customers.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65510-cvs-caremark-to-stop-selling-tobacco-products-at-cvs-pharmacy-locations
CVS Caremark Corporation (NYSE: CVS) announced today that it is changing its corporate name to CVS Health to reflect its broader health care commitment and its expertise in driving the innovations needed to shape the future of health.
As a further demonstration of its commitment to health, CVS Health also announced the end of tobacco sales at CVS/pharmacy as of September 3, nearly a month ahead of the previously targeted date of October 1. In February, the company announced that it would end the sale of cigarettes and tobacco products at its CVS/pharmacy stores, making CVS/pharmacy the first and only national pharmacy chain to take this step in support of the health and well-being of its patients and customers.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7308951-cvs-caremark-announces-corporate-name-change-to-cvs-health/
To help Americans determine their risk for chronic diseases and get them on a path to better health, CVS/pharmacy announced today the launch of the 2011 “To Your Health” program, offering free preventive health screenings at more than 800 events in communities across the country. The program will get underway in Houston on Saturday, March 5th, and continue in Dallas, Los Angeles, Washington D.C., Atlanta, Philadelphia, Chicago and Miami.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/48303/
We've heard that some of you love the baby kissing the mirror from our latest family products TV commercial. So here, for your viewing pleasure, is some behind the scenes footage. We think he's just gorgeous! http://www.medibank.com.au/healthcover/families-children-health-insurance.aspx
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
